Profil
Scott L.
Young worked as a Principal at Genetics Institute LLC and Genzyme Corp.
He was also the Chief Operating Officer at Oncotelic Therapeutics, Inc. and Aldeyra Therapeutics, Inc. Additionally, he served as the Chief Operating Officer at Link Medicine Corp.
from 2006 to 2012.
Young received his undergraduate degree from the University of Massachusetts.
Anciens postes connus de Scott L. Young
| Sociétés | Poste | Fin |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Directeur des opérations | 30/08/2016 |
| ONCOTELIC THERAPEUTICS, INC. | Directeur des opérations | 14/08/2006 |
| University of Massachusetts | Corporate Officer/Principal | - |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| REPLIGEN CORPORATION | Corporate Officer/Principal | - |
Formation de Scott L. Young
| University of Massachusetts | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| REPLIGEN CORPORATION | Health Technology |
| ALDEYRA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Link Medicine Corp.
 Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
